The Role of Consumption of Alpha-Linolenic, Eicosapentaenoic and Docosahexaenoic Acids in Human Metabolic Syndrome and Type 2 Diabetes- A Mini-Review
Tóm tắt
Từ khóa
Tài liệu tham khảo
2. Krauss, R.M. Lipids and lipoproteins in patients with type 2 diabetes. Diabetes Care. 27, 1496-1504 (2004).
4. Scheffer, P.G.; Henry, R.M.A.; Wever, E.J.M. et al. LDL oxidative modifications in well- or moderately controlled type 2 diabetes. Diabetes/Metabolism Research and Reviews 20, 298-304 (2004).
7. Pi-Sunyer, F.X. Pathophysiology and long-term management of the metabolic syndrome. Obesity Research 12, 174S-180S (2004).
8. Feskens, E.J.M.; Bowles, C.H.; Kromhout, D. Inverse association between fish intake and risk of glucose intolerance in normoglycemic elderly men and women. Diabetes Care 14, 935-941 (1991).
11. Nkondjock, A.; Receveur, O. Fish-seafood consumption, obesity and the risk of type 2 diabetes, an ecological study. Diabetes. Metab. 29, 635-642 (2003).
12. Klein-Platat, C.; Drai, J.; Oujaa, M. et al. Plasma fatty acid composition is associated with the metabolic syndrome and low-grade inflammation in overweight adolescents. Am. J. Clin. Nutr. 82, 1178-1184 (2005).
13. Phinney, S.D. Fatty acids, inflammation, and the metabolic syndrome. Am. J. Clin. Nutr. 82, 1151-1152 (2005).
15. Das, U.N. Pathophysiology of metabolic syndrome X and its links to the perinatal period. Nutrition 21, 762-773 (2005b).
17. Jellema, A.; Plat, J.; Mesnink, R.P. Weight reduction, but not moderate intake of fish oil, lowers concentration of inflammatory markers and PAI-1 antigen in obese men during the fasting and postprandial state. Eur. J. Clin. Nutr. 34, 766-773 (2004).
18. Reseland, J.E.; Anderssen, S.A.; Solvoll, K.; Hjermann, I.; Urdal, P.; Holme, I.; Drevon, C.A. Effect of long-term changes in diet and exercise on plasma leptin concentrations. Am. J. Clin. Nutr. 73, 240-245 (2001).
19. Krebs, J.D.; Browning, L.M.; McLean, N.K.; Rothwell, J.L.; Mishra, G.D.; Moore, C.S.; Jebb, S.A. Additive benefits of long-chain n-3 polyunsaturated fatty acids and weight-loss in the management of cardiovascular disease risk in overweight hyperinsulinaemic women. Int. J. Obesity 30, 1535-1544 (2006).
20. Horrobin, D.F. Fatty acid metabolism in health and disease,the role of delta-6-desaturase. Am. J. Clin. Nutr. 57S, 732S-736S (1993).
21. Zamaria, N. Alteration of polyunsaturated fatty acid status and metabolism in health and disease. Reprod. Nutr. Dev. 44, 273-282 (2004).
22. Denke, M.A. Clinical cardiology, physician update. Dietary prescriptions to control dyslipidemias. Circulation 105, 132-135 (2002).
23. Szapary, P.O.; Rader, D.J. Pharmacological management of high triglycerides and low high density lipoprotein cholesterol. Curr. Opin. Pharmacol. 1, 113-120 (2001).
24. Cottrell D.A.; Marshall B.J.; Falko, J.M. Therapeutic approaches to dyslipidemia in diabetes mellitus and metabolic syndrome. Curr. Opin. Cardiol. 18, 301-308 (2003).
25. Barrett, P.H.R.; Watts, G.F. Kinetic studies of lipoprotein metabolism in the metabolic syndrome including the effects of nutritional interventions. Curr. Opin. Lipidol. 14, 61-68 (2003).
26. McCarty, M.F. Complementary measures for promoting insulin sensitivity in skeletal muscle. Medical Hypotheses 51, 451-464 (1998).
28. Wong, S-H.; Marsh, J.B. Inhibition of apolipoprotein secretion and phospahtidate phosphohydrolase activity by eicosapentaenoic and docosahexaenoic acids in the perfused rat liver. Metabolism 37, 1177-1181 (1988).
1992, 1126, 199
33. Brady, L.M.; Lovegrove, S.S.; Lesauvage, S.V.M. et al. Increased n-6 polyunsaturated fatty acids do not attenuate the effects of long chain n-3 polyunsaturated fatty acids on insulin sensitivity of triacylglycerol reduction in Indian Asians. Am. J. Clin. Nutr. 79, 983-991 (2004).
35. Nomura, S.; Kanazawa, S.; Fukuhara, S. Effects of eicosapentaenoic acid on platelet activation markers and cell adhesion molecules in hyperlipidemic patients with type 2 diabetes. J. Diabetes Complications 17, 153-159 (2003).
36. Pedersen, H.; Petersen, M.; Major-Pedersen, A. et al. Influence of fish oil supplementation on in vivo and in vitro oxidation resistance of low-density lipoprotein in type 2 diabetes. Eur. J. Clin. Nutr. 57, 713-720 (2003).
37. Chan, D.C.; Barrett, H.P.R.; Watts G.F. Dyslipidemia in visceral obesity. Mechanism, implications and therapy. Am. J. Cardiovasc. Drugs 4, 227-246 (2004).
38. Annuzi, G.; Rivellese, A.; Capaldo, B. et al. A controlled study of the effects of n-3 fatty acids on lipid and glucose metabolism in non-insulin-dependent diabetic patients. Atherosclerosis 87, 65-73 (1991).
39. Jain, S.; Gaiha, M.; Bhattacharjee, S. et al. Effects of low dose ω-3 fatty acid substitution in type-2 diabetes mellitus with special reference to oxidative stress-a prospective preliminary study. J. Assoc. Physicians India 50, 1028-1033 (2002).
NAKAMURA N, 1998, 12, 311
43. Friedberg, C.E.; Heine, R.J.; Janssen, M.J.F.M.; Grobbee DE. Fish oil and glycemic control in diabetes. Diabetes Care 21, 494-500 (1998).
44. Rivellese, A.A.; Annuzi, G.; Maffettone, A. et al. Long-term effects of fish oil on insulin resistance and plasma lipoproteins in NIDDM patients with hypertriglyceridemia. Diabetes Care 19, 1207-1213 (1996).
45. Popp-Snijders, C.; Schouten, J.A.; Heine, R.J. et al. Dietary supplementation of omega-3 polyunsaturated fatty acids improves insulin sensitivity in non-insulin-dependent diabetes. Diabetes Research 4,141-147 (1987).
46. Montori, V.M.; Wollan, P.C.; Farmer, A.: Dinneen S.F. Fish oil supplementation in type 2 diabetes. Diabetes Care 23,1407-1415 (2000).
47. Petersen, M.; Jensen, T.; Pedersen, H. et al. Effect of fish oil versus corn oil supplementation on LDL and HDL subclasses in type 2 diabetic patients. Diabetes Care 25, 1704-1708 (2002).
48. Glauber, H.; Wallace, P.; Griver, K. et al. Adverse metabolic effect of omega-3 fatty acids in non-insulin-dependent diabetes mellitus. Ann. Intern. Med. 108, 663-668 (1998).
49. Woodman, R.J.; Mori, T.A.; Burke, V.A. et al. Effects of purified eicospentaenoic and doscosahexaenoic acids on glycemic control.; blood pressure and serum lipids in type 2 diabetic patients with treated hypertension. Am. J. Clin. Nutr. 76, 1007-1015 (2002).
50. Rivellese, A.A.; Lilli, S. Quality of dietary fatty acids, insulin sensitivity and type 2 diabetes. Biomed. Pharmacother. 57, 84-87 (2003).
53. Drevon, C.A. Fatty acids and the expression of adipokines. Biochim. Biophys. Acta 1740, 287-292 (2005).
54. Woodman, R.J.; Mori, T.A.; Burke, V.A. et al. Effects of purified eicospentaenoic and doscosahexaenoic acid on platelet, fibrinolytic and vascular function in hypertensive type 2 diabetic patients. Atherosclerosis 166, 85-93 (2003).
57. McManus, R.M.; Clandinin, M.T.; Jumpson, J. et al. A comparison of the effects of n-3 fatty acids from linseed oil and fish oil in well-controlled type 2 diabetes. Diabetes Care 19, 463-467 (1996).
58. Goh, Y.K.; Jumpsen, J.A.; Ryan, E.A.; Clandinin, M.T. Effect of ω3 fatty acid on plasma lipids, cholesterol and fatty acid content in NIDDM patients. Diabetologia 40, 45-52 (1997).
59. Hu, F.B.; Cho, E.; Rexrode, K.M. et al. Fish and long chain ω-3 fatty acid intake and the risk of coronary heart disease and total mortality in diabetic women. Circulation 107, 1852-1857 (2003).
60. Basu, A.; Devaraj, S.; Jialal, I. Dietary factors that promote or retard inflammation. Arterio. Thromb. Vasc. Biol. 26, 995-1001 (2006).